(Q44615409)

English

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production

scientific article published in October 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production (English)

1 reference

Europe PubMed Central

4 December 2017

apoptotic process

1 reference

based on heuristic

inferred from title

author name string

Ann-Marie Simeone

1

1 reference

Europe PubMed Central

4 December 2017

Lyle David Broemeling

2

1 reference

Europe PubMed Central

4 December 2017

Josh Rosenblum

3

1 reference

Europe PubMed Central

4 December 2017

Ana Maria Tari

4

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

22

1 reference

Europe PubMed Central

4 December 2017

43

1 reference

Europe PubMed Central

4 December 2017

6739-6747

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206786

0 references

Biotransformation and cytotoxic properties of NO-donors on MCF7 and U251 cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Distribution of fenretinide in the mammary gland of breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Nitric oxide synthase activity in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

21 January 2018

Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoprevention of breast cancer: the Italian experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206786

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1206786

1 reference

Europe PubMed Central

4 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44615409&oldid=2029384845"